FDA Panel Largely Pans Trial Data for Myopia Eye Drops

(MedPage Today) -- The regulatory status of a low-dose atropine eye drop formulation for myopia remained unresolved following a day-long FDA advisory committee meeting, but closing comments did not bode well for SYD-101. The Dermatologic and Ophthalmic...